Commission Directive 2008/66/EC [Commission Directive 2008/66/EC of 30 June 2008 amending Council Directive 91/414/EEC to include bifenox, diflufenican, fenoxaprop-P, fenpropidin and quinoclamine as active substances (OJ L 171, 1.7.2008, p. 9, ELI: http://data.europa.eu/eli/dir/2008/66/oj).] included fenoxaprop-P in Annex I to Directive 91/414/EEC as an active substance until 31 December 2018 and it was subsequently included in Part A of the Annex to Implementing Regulation (EU) No 540/2011. The approval of fenoxaprop-P was extended nine times, most recently by Implementing Regulation (EU) 2025/787 until 30 November 2026.
Recital 3, Regulation (EU) 2026/2348
In force
Commission Implementing Regulation (EU) No 540/2011 of 25 May 2011 implementing Regulati…Law
- celex=31991L0414
- celex=32008L0066
- num:eu=1991/414